Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded by Andrew Worden, Lifespan Vision Ventures is based in Connecticut, United States, and focuses on investing in companies developing therapeutics for longevity and aging reversal. The firm manages a portfolio of 20 companies and aims to enable a healthy lifespan that extends beyond 120 years.
Lifespan Vision Ventures invests in early to mid-stage companies within the biotechnology and longevity sectors, participating in angel, seed, and pre-seed rounds. The firm emphasizes collaboration with academics and professionals to accelerate development timelines for healthspan-related innovations.
Notable portfolio companies include Algen Biotechnologies, which utilizes CRISPR and AI for precision medicines; EpiBone, focused on skeletal reconstruction; and Rejuvenate Bio, which develops gene therapies to reverse aging. Other companies include SENISCA, Bolden Therapeutics, and Fauna Bio.
Submit your pitch through their website's contact form.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.